AGIO Insider Transactions — Page 3
638 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 201–300; provenance stays internal.
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| MARAGANORE JOHN | Director | 2018-09-12 | Sale | 0.0 | — |
| MARAGANORE JOHN | Director | 2018-09-12 | Sale | 14,162.0 | $71.74 |
| MARAGANORE JOHN | Director | 2018-09-11 | Sale | 2,400.0 | $73.82 |
| MARAGANORE JOHN | Director | 2018-09-11 | Sale | 11,155.0 | $72.52 |
| Alenson Carman | Principal Accounting Officer | 2018-09-05 | Sale | 312.0 | $83.0 |
| Biller Scott | Chief Scientific Officer | 2018-09-05 | Sale | 100.0 | $84.38 |
| Biller Scott | Chief Scientific Officer | 2018-09-05 | Sale | 2,260.0 | $83.17 |
| Biller Scott | Chief Scientific Officer | 2018-09-05 | Sale | 640.0 | $82.52 |
| Bowden Christopher | Chief Medical Officer | 2018-08-30 | Sale | 1,700.0 | $80.03 |
| Bowden Christopher | Chief Medical Officer | 2018-08-29 | Sale | 300.0 | $80.0 |
| Hoerter Steven L. | Chief Commercial Officer | 2018-08-24 | Sale | 2,050.0 | $74.92 |
| Biller Scott | Chief Scientific Officer | 2018-08-06 | Sale | 600.0 | $80.87 |
| Biller Scott | Chief Scientific Officer | 2018-08-06 | Sale | 2,100.0 | $80.15 |
| Biller Scott | Chief Scientific Officer | 2018-08-06 | Sale | 300.0 | $78.32 |
| Hoerter Steven L. | Chief Commercial Officer | 2018-07-25 | Sale | 2,050.0 | $84.58 |
| Bowden Christopher | Chief Medical Officer | 2018-07-10 | Sale | 800.0 | $87.26 |
| Bowden Christopher | Chief Medical Officer | 2018-07-10 | Sale | 1,200.0 | $86.42 |
| Alenson Carman | Principal Accounting Officer | 2018-07-09 | Sale | 272.0 | $84.94 |
| Biller Scott | Chief Scientific Officer | 2018-07-05 | Sale | 300.0 | $84.32 |
| Biller Scott | Chief Scientific Officer | 2018-07-05 | Sale | 2,700.0 | $83.41 |
| Hoerter Steven L. | Chief Commercial Officer | 2018-06-22 | Sale | 2,050.0 | $97.58 |
| Foster-Cheek Kaye I | Director | 2018-06-14 | Sale | 839.0 | $94.3 |
| Foster-Cheek Kaye I | Director | 2018-06-14 | Sale | 5,980.0 | $93.78 |
| Foster-Cheek Kaye I | Director | 2018-06-14 | Sale | 2,181.0 | $92.62 |
| Bowden Christopher | Chief Medical Officer | 2018-06-12 | Sale | 200.0 | $93.37 |
| Bowden Christopher | Chief Medical Officer | 2018-06-12 | Sale | 1,800.0 | $92.84 |
| Biller Scott | Chief Scientific Officer | 2018-06-05 | Sale | 939.0 | $94.28 |
| Biller Scott | Chief Scientific Officer | 2018-06-05 | Sale | 1,259.0 | $93.27 |
| Biller Scott | Chief Scientific Officer | 2018-06-05 | Sale | 802.0 | $92.45 |
| Schenkein David P | Chief Executive Officer | 2018-06-01 | Sale | 100.0 | $96.91 |
| Schenkein David P | Chief Executive Officer | 2018-06-01 | Sale | 3,190.0 | $96.4 |
| Schenkein David P | Chief Executive Officer | 2018-06-01 | Sale | 8,200.0 | $95.11 |
| Schenkein David P | Chief Executive Officer | 2018-06-01 | Sale | 1,510.0 | $94.37 |
| Schenkein David P | Chief Executive Officer | 2018-05-30 | Sale | 45,626.0 | $90.07 |
| Schenkein David P | Chief Executive Officer | 2018-05-23 | Sale | 299.0 | $92.03 |
| Schenkein David P | Chief Executive Officer | 2018-05-23 | Sale | 9,301.0 | $91.6 |
| Schenkein David P | Chief Executive Officer | 2018-05-23 | Sale | 39,774.0 | $90.11 |
| Hoerter Steven L. | Chief Commercial Officer | 2018-05-23 | Sale | 2,050.0 | $85.76 |
| Biller Scott | Chief Scientific Officer | 2018-05-23 | Sale | 15,177.0 | $90.0 |
| Bowden Christopher | Chief Medical Officer | 2018-05-11 | Sale | 1,160.0 | $85.14 |
| Bowden Christopher | Chief Medical Officer | 2018-05-11 | Sale | 840.0 | $84.81 |
| Bowden Christopher | Chief Medical Officer | 2018-05-08 | Sale | 2,000.0 | $81.38 |
| Biller Scott | Chief Scientific Officer | 2018-05-07 | Sale | 3,000.0 | $81.81 |
| Schenkein David P | Chief Executive Officer | 2018-05-01 | Sale | 100.0 | $84.35 |
| Schenkein David P | Chief Executive Officer | 2018-05-01 | Sale | 2,814.0 | $83.56 |
| Schenkein David P | Chief Executive Officer | 2018-05-01 | Sale | 10,086.0 | $82.88 |
| Hoerter Steven L. | Chief Commercial Officer | 2018-04-23 | Sale | 2,050.0 | $85.95 |
| Bowden Christopher | Chief Medical Officer | 2018-04-12 | Sale | 700.0 | $85.68 |
| Bowden Christopher | Chief Medical Officer | 2018-04-12 | Sale | 1,300.0 | $84.78 |
| Biller Scott | Chief Scientific Officer | 2018-04-05 | Sale | 500.0 | $77.17 |
| Biller Scott | Chief Scientific Officer | 2018-04-05 | Sale | 800.0 | $76.17 |
| Biller Scott | Chief Scientific Officer | 2018-04-05 | Sale | 400.0 | $75.04 |
| Biller Scott | Chief Scientific Officer | 2018-04-05 | Sale | 1,300.0 | $73.9 |
| Schenkein David P | Chief Executive Officer | 2018-04-02 | Sale | 2,113.0 | $79.49 |
| Schenkein David P | Chief Executive Officer | 2018-04-02 | Sale | 3,390.0 | $78.59 |
| Schenkein David P | Chief Executive Officer | 2018-04-02 | Sale | 3,340.0 | $77.76 |
| Schenkein David P | Chief Executive Officer | 2018-04-02 | Sale | 2,600.0 | $76.4 |
| Schenkein David P | Chief Executive Officer | 2018-04-02 | Sale | 1,557.0 | $75.54 |
| Hoerter Steven L. | Chief Commercial Officer | 2018-03-22 | Sale | 2,050.0 | $84.65 |
| Foster-Cheek Kaye I | Director | 2018-03-19 | Sale | 6,800.0 | $81.97 |
| Scadden David | Director | 2018-03-16 | Purchase | 200.0 | $83.44 |
| Bowden Christopher | Chief Medical Officer | 2018-03-14 | Sale | 300.0 | $82.9 |
| Bowden Christopher | Chief Medical Officer | 2018-03-14 | Sale | 1,700.0 | $82.23 |
| Biller Scott | Chief Scientific Officer | 2018-03-05 | Sale | 1,100.0 | $84.1 |
| Biller Scott | Chief Scientific Officer | 2018-03-05 | Sale | 1,100.0 | $83.21 |
| Biller Scott | Chief Scientific Officer | 2018-03-05 | Sale | 400.0 | $82.04 |
| Biller Scott | Chief Scientific Officer | 2018-03-05 | Sale | 400.0 | $80.93 |
| Schenkein David P | Chief Executive Officer | 2018-03-01 | Sale | 10,085.0 | $81.3 |
| Schenkein David P | Chief Executive Officer | 2018-03-01 | Sale | 2,915.0 | $80.38 |
| Hoerter Steven L. | Chief Commercial Officer | 2018-02-22 | Sale | 2,050.0 | $78.63 |
| Bowden Christopher | Chief Medical Officer | 2018-02-16 | Sale | 500.0 | $78.08 |
| Bowden Christopher | Chief Medical Officer | 2018-02-16 | Sale | 1,500.0 | $77.51 |
| Biller Scott | Chief Scientific Officer | 2018-02-05 | Sale | 400.0 | $78.03 |
| Biller Scott | Chief Scientific Officer | 2018-02-05 | Sale | 701.0 | $76.76 |
| Biller Scott | Chief Scientific Officer | 2018-02-05 | Sale | 1,100.0 | $75.7 |
| Biller Scott | Chief Scientific Officer | 2018-02-05 | Sale | 799.0 | $74.89 |
| Bowden Christopher | Chief Medical Officer | 2018-02-01 | Sale | 685.0 | $79.23 |
| Bowden Christopher | Chief Medical Officer | 2018-02-01 | Sale | 1,315.0 | $78.5 |
| Schenkein David P | Chief Executive Officer | 2018-02-01 | Sale | 4,460.0 | $79.23 |
| Schenkein David P | Chief Executive Officer | 2018-02-01 | Sale | 8,540.0 | $78.5 |
| Schenkein David P | Chief Executive Officer | 2018-01-26 | Sale | 2,966.0 | $82.22 |
| Schenkein David P | Chief Executive Officer | 2018-01-26 | Sale | 11,369.0 | $81.4 |
| Schenkein David P | Chief Executive Officer | 2018-01-26 | Sale | 9,237.0 | $80.35 |
| Schenkein David P | Chief Executive Officer | 2018-01-24 | Sale | 20.0 | $80.01 |
| Schenkein David P | Chief Executive Officer | 2018-01-24 | Sale | 13,533.0 | $80.01 |
| CELGENE CORP /DE/ | TenPercentOwner | 2018-01-23 | Purchase | 851,154.0 | $67.0 |
| Celgene European Investment Co LLC | TenPercentOwner | 2018-01-23 | Purchase | 851,154.0 | $67.0 |
| Celgene Alpine Investment Co., LLC | TenPercentOwner | 2018-01-23 | Purchase | 851,154.0 | $67.0 |
| Celgene Switzerland LLC | TenPercentOwner | 2018-01-23 | Purchase | 851,154.0 | $67.0 |
| Hoerter Steven L. | Chief Commercial Officer | 2018-01-23 | Sale | 25,000.0 | $74.83 |
| Schenkein David P | Chief Executive Officer | 2018-01-23 | Sale | 32,875.0 | $80.01 |
| CELGENE CORP /DE/ | TenPercentOwner | 2018-01-23 | Purchase | 851,154.0 | $67.0 |
| Celgene European Investment Co LLC | TenPercentOwner | 2018-01-23 | Purchase | 851,154.0 | $67.0 |
| Celgene Alpine Investment Co., LLC | TenPercentOwner | 2018-01-23 | Purchase | 851,154.0 | $67.0 |
| Celgene Switzerland LLC | TenPercentOwner | 2018-01-23 | Purchase | 851,154.0 | $67.0 |
| Schenkein David P | Chief Executive Officer | 2018-01-16 | Sale | 6,597.0 | $74.8 |
| Schenkein David P | Chief Executive Officer | 2018-01-16 | Sale | 10,914.0 | $74.11 |
| Schenkein David P | Chief Executive Officer | 2018-01-16 | Sale | 22,304.0 | $73.02 |
| Schenkein David P | Chief Executive Officer | 2018-01-16 | Sale | 13,185.0 | $71.77 |
| Alenson Carman | Principal Accounting Officer | 2018-01-12 | Sale | 2,150.0 | $75.0 |